We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Perseris

News List

Indivior lays out restructuring plans to cut down expenses pharmaceutical-technology
September 27, 2020
UK-based pharmaceutical firm Indivior has stated that it is taking organisational and cost actions to adjust its abilities and resources to meet its strategic priorities.
Indivior hit hard as generic Suboxone defence crumbles pharmaphorum
November 26, 2018
Indivior has suffered a critical defeat in the US courts for opioid addiction product Suboxone Film, opening the door to generic competition and sparking a run on its shares.
Perseris Now Available in the U.S. for the Treatment of Schizophrenia in Adults americanpharmaceuticalreview
November 20, 2018
Indivior announced that Perseris (risperidone) for extended-release injectable suspension is now available in the United